Patents by Inventor Daniel A. Webb

Daniel A. Webb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NON-IONIC SURFACTANTS AND METHODS OF MAKING AND USING THE SAME
    Publication number: 20260337341
    Abstract: Disclosed herein are aspects of a compound according to Formula I or Formula V The compounds are useful as surfactants and can be used in applications for which a surfactant is indicated. The disclosed compounds are biodegradable and do not form toxic by-products when degraded. As such, the disclosed compounds can be used as replacements for current surfactants, such as current octylphenol ethoxylates (OPEs) and nonylphenol ethoxylates (NPEs) that have toxic effects when degraded. Also disclosed are aspects of a method for making the compounds and methods for using the compounds in cell assays.
    Type: Application
    Filed: December 22, 2025
    Publication date: October 29, 2026
    Applicant: Life Technologies Corporation
    Inventors: Premchendar Nandhikonda, Schuyler B. Corry, Penny J. Jensen, Eron Saxon, Daniel A. Webb
  • NON-IONIC SURFACTANTS AND METHODS OF MAKING AND USING THE SAME
    Publication number: 20260184995
    Abstract: Disclosed herein are compounds that can be used as surfactants for various applications. The disclosed compounds are biodegradable and do not form toxic by-products when degraded. As such, the disclosed compounds can be used as replacements for current surfactants, such as current octylphenol ethoxylates (OPEs) and nonylphenol ethoxylates (NPEs) that have toxic effects when degraded. Also disclosed are methods of making and using the disclosed compounds.
    Type: Application
    Filed: December 22, 2025
    Publication date: July 2, 2026
    Applicant: Life Technologies Corporation
    Inventors: Premchendar Nandhikonda, Daniel A. Webb
  • GABA(A) RECEPTOR MODULATORS AND METHODS TO CONTROL SMOOTH MUSCLE CONTRACTION AND INFLAMMATION
    Publication number: 20260125388
    Abstract: Substituted [benzo[f]imidazo[1,5-a][1,4]diazepine]-3-carboxylic acid compounds are GABA(A) receptor modulators and have utility to treat inflammation and/or inhibit smooth muscle contraction.
    Type: Application
    Filed: October 4, 2023
    Publication date: May 7, 2026
    Inventors: Alexander E. Arnold, Michelle J. Meyer, Daniel A. Webb, Douglas C. Stafford, Charles W. Emala